A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis

Enrolling by invitationOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

March 25, 2025

Conditions

Subclinical Psoriatic Arthritis

Interventions

DRUG

Biologics

The ultrasonic changes of synovitis and enthesitis were observed after 12 weeks of treatment with biologic agents

Trial Locations (1)

First Affiliated Hospital of Fujian Medical University, Fuzhou